Productrx Consulting Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -38.03%
- Profit Growth 259.55%
- Ebitda 73.32%
- Net Worth 4.92%
- Total Assets 75.46%
About Productrx Consulting
Productrx Consulting Private Limited (PCPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 May 2011 and has a history of 13 years and eight months. Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ravi Subramanyam and Vishali Rangavajhula serve as directors at the Company.
Company Details
-
Location
Gurugram, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74990HR2011PTC042958
-
Company No.
042958
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 May 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Productrx Consulting Private Limited offer?
Productrx Consulting Private Limited offers a wide range of products and services, including Business Planning and Management, Business Consultant, Product Development Research, Technology Development Services, ERP Packages.
Who are the key members and board of directors at Productrx Consulting?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Subramanyam
|
Director | 16-May-2011 | Current |
|
Vishali Rangavajhula
|
Director | 29-Aug-2018 | Current |
Financial Performance of Productrx Consulting.
Productrx Consulting Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 38.03% decrease. The company also saw a substantial improvement in profitability, with a 259.55% increase in profit. The company's net worth moved up by a moderate rise of 4.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Productrx Consulting?
In 2017, Productrx Consulting had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Productrx Consulting?
Unlock and access historical data on people associated with Productrx Consulting, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Productrx Consulting, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Productrx Consulting's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
